Does Tauroursodeoxycholic Acid (TUDCA) Treatment Increase Hepatocyte Proliferation In Patients With Chronic Liver Disease

Effect Increase
Trial Design Non-controlled trial
Trial Length n/a
Number of Subjects 5
Sex n/a
Notes for this study:
TUDCA, at 10-13mg daily for 3 months, was able to reduce ALT levels and increase the rate of liver cell differentiation and proliferation.